@article{6e949a71ff07480d8e1ab505c46d7ee8,
title = "Automated {\textquoteleft}oscillometric{\textquoteright} blood pressure measuring devices: how they work and what they measure",
abstract = "Automated {\textquoteleft}oscillometric{\textquoteright} blood pressure (BP) measuring devices (BPMDs) were developed in the 1970s to replace manual auscultatory BP measurement by mercury sphygmomanometer. Automated BPMDs that have passed accuracy testing versus a reference auscultatory sphygmomanometer using a scientifically accepted validation protocol are recommended for clinical use globally. Currently, there are many thousands of unique automated BPMDs manufactured by hundreds of companies, with each device using proprietary algorithms to estimate BP and using a method of operation that is largely unchanged since inception. Validated automated BPMDs provide similar BP values to those recorded using manual auscultation albeit with potential sources of error mostly associated with using empirical algorithms to derive BP from waveform pulsations. Much of the work to derive contemporary BP thresholds and treatment targets used to manage cardiovascular disease risk was obtained using automated BPMDs. While there is room for future refinement to improve accuracy for better individual risk stratification, validated BPMDs remain the recommended standard for office and out-of-office BP measurement to be used in hypertension diagnosis and management worldwide.",
author = "Sharman, {James E.} and Isabella Tan and Stergiou, {George S.} and Carolina Lombardi and Francesca Saladini and Mark Butlin and Raj Padwal and Kei Asayama and Alberto Avolio and Brady, {Tammy M.} and Alan Murray and Gianfranco Parati",
note = "Funding Information: AA is on the Scientific Advisory Board of CardieX, maker of pulse wave analysis devices, and member of the IEEE Standards Working Group for cuffless blood pressure devices. AM is the principal investigator in blood pressure measurement research funded by the UK Engineering and Physical Sciences Research Council. JES is a consultant of HEARTS in the Americas, an initiative of the Pan American Health Organization. JES is principal investigator of a National Health and Medical Research Council partnership grant (S0026615) that includes a medical technology company that manufactures a central blood pressure monitor. IT is an employee of ATCOR, CardieX Ltd, manufacturer of the SphygmoCor(R) system for non-invasive central aortic blood pressure measurement. MB has in the past 12 months conducted contract research for CardieX AtCor Medical. RP is CEO of mmHg Inc., maker of cloud-based remote patient monitoring and digital health solutions. GSS is chairing the STRIDE BP organisation for blood pressure measurement methods and devices, conducted validation studies of blood pressure monitors, and advised manufacturers on device and software development. KA received research support from Omron Healthcare. TMB is co-chair of the Association for the Advancement of Medical Instrumentation Sphygmomanometer committee. TMB is co-chair of the American Medical Association{\textquoteright}s Validated Device Listing Independent Review Committee. TMB has also received funding research or salary support from Resolve to Save Lives. Resolve to Save Lives is funded by Bloomberg Philanthropies, the Bill and Melinda Gates Foundation, and Gates Philanthropy. Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2023",
month = feb,
doi = "10.1038/s41371-022-00693-x",
language = "English (US)",
volume = "37",
pages = "93--100",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "2",
}